the dyevert equipment is approx 350GBP per patient. No OSP don't make the dye, they make the equipment that results in approx 40% less dye used for same image quality. The result is less dye used to prevent any kidney failure issues and reduced overall costs. Even at a discount less GE sales commissions, GE are able to sell this add on to their existing customers this will result in significant growth for OSP particularly when COVID levels drop. I suspect OSP have conservative growth levels despite the GE agreement due to COVID so there is only upside and earlier cash flow positivity from here
- Forums
- ASX - By Stock
- Ann: GE Healthcare to Distribute Osprey Medical Technology
the dyevert equipment is approx 350GBP per patient. No OSP...
-
- There are more pages in this discussion • 257 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online